1.1.1.145	additional information	no reaction with 3-acetylpyridine-adenine dinucleotide, nicotinamide-hypoxanthine dinucleotide, 3-acetylpyridine-hypoxanthine dinucleotide	389376	
1.1.1.145	additional information	no significant activity with NAD+/NADH	684725	
1.1.1.145	NAD+	-	2884, 2898, 389370, 389371, 389373, 389374, 389376, 389378, 389379, 389380, 389382, 389383, 389384, 389385, 389386, 389387, 389388, 389389, 389390, 389391, 389392, 389393, 389395, 389396, 389397, 389399, 389400, 389401, 389402, 656091, 656652, 656655, 662371, 667452, 668423, 670036, 670037, 693887, 699845, 700182, 700557, 740503, 740914, 740998, 741250, 741261, 741423, 763397	
1.1.1.145	NAD+	cysteinyl and histidyl at NAD+-binding site	389369	
1.1.1.145	NAD+	more than 10fold as active as NADP+	389372	
1.1.1.145	NAD+	NADH forms hydrogen bond with Asp35 in the NADH-wild-type 3beta-HSD1 complex	725612	
1.1.1.145	NAD+	optimum coenzyme concentration is 1.5 mmol/l	763139	
1.1.1.145	NAD+	preferred	389377	
1.1.1.145	NADH	-	662371, 669061, 699111	
1.1.1.145	NADP+	-	389371, 389378, 389402, 684725